You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,943,166


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,943,166
Title: Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
Abstract:The present invention relates to highly selective phosphodieterase (PDE) enzyme inhibitors and to their use in pharmaceutical articles of manufacture. In particular, the present invention relates to potent inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase type 5 (PDE5) that when incorporated into a pharmaceutical product at about 1 to about 20 mg unit dosage are useful for the treatment of sexual dysfunction.
Inventor(s): Pullman; William Ernest (Far Hills, NJ), Whitaker; John Steven (Woodinville, WA)
Assignee: Lilly ICOS LLC. (Wilmington, DE)
Application Number:10/031,556
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,943,166
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,943,166: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors and companies for their intellectual property. Analyzing the scope and claims of a patent is crucial for understanding its impact, validity, and potential for litigation. This article will delve into the specifics of United States Patent 6,943,166, exploring its claims, the patent landscape, and relevant legal and technical aspects.

Patent Overview

United States Patent 6,943,166, hereafter referred to as the '166 patent, is a utility patent granted by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first understand the general structure and content of a patent document.

Claims of the Patent

The claims section of a patent is the most critical part, as it defines the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to one or more previous claims[5].

Independent Claims

Independent claims in the '166 patent would outline the broadest aspects of the invention. These claims are essential because they define the core of what the patent covers.

Dependent Claims

Dependent claims build upon the independent claims, adding specific details or limitations. These claims help to narrow down the scope and provide additional protection by covering various embodiments of the invention.

Patent Scope and Coverage

The scope of a patent is determined by its claims, and it is crucial to understand what is included and excluded.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is often a point of contention in patent litigation, as different parties may have different interpretations of what the claims cover[1].

Patent Scope Measurements

The USPTO provides tools and datasets, such as the Patent Claims Research Dataset, to analyze patent scope. This dataset includes detailed information on claims from U.S. patents and can help in understanding the breadth and depth of patent coverage[3].

Patent Landscape

The patent landscape refers to the broader context of related patents and intellectual property in the same field.

Related Patents and Applications

Using tools like the Global Dossier and the Common Citation Document (CCD), one can identify related patents and applications filed at participating IP Offices. This helps in understanding the family of patents and any potential overlaps or conflicts[4].

Industry Trends

Analyzing industry trends and the types of patents being filed in the same field can provide insights into the competitive landscape. For example, the increase in software-related patents has been a significant trend in recent years, contributing to a rise in patent litigation[1].

Legal Considerations

Presumption of Validity

Each claim of a patent is presumed valid, but this presumption can be challenged through various legal mechanisms such as inter partes review (IPR) or litigation[5].

Obviousness-Type Double Patenting (ODP)

ODP is a legal doctrine that can invalidate patent claims if they are deemed to be obvious variations of earlier patents. This was a key issue in cases like the Cellect LLC appeal, where multiple related patents were found to be unpatentable due to ODP[2].

Patent Term Adjustment (PTA)

Patent Term Adjustment (PTA) can extend the life of a patent due to delays in the prosecution process. However, this must be carefully managed to avoid issues like those seen in the Cellect LLC case, where PTA grants affected the expiration dates of related patents[2].

Litigation and Enforcement

Patent litigation is a significant aspect of the patent landscape. Understanding the factors that contribute to litigation can help in managing and enforcing patents effectively.

Factors Contributing to Litigation

Stakeholders have identified several factors that contribute to the increase in patent litigation, including changes in patent laws like the America Invents Act (AIA) and the rise of non-practicing entities (NPEs)[1].

Recent Trends

From 2000 to 2011, there was a notable increase in patent infringement lawsuits, particularly in the software sector. This trend highlights the importance of careful patent drafting and strategic management of intellectual property[1].

Best Practices for Patent Holders

Conducting Thorough Searches

Using resources like the USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) can help in conducting thorough searches to identify potential conflicts and ensure the novelty of an invention[4].

Regularly Reviewing and Updating Patents

Given the dynamic nature of technology and law, it is essential to regularly review and update patents to ensure they remain relevant and valid.

Key Takeaways

  • Claims Analysis: The claims section is the heart of a patent, defining what is protected and what is not.
  • Patent Scope: Understanding the scope of a patent involves interpreting claims and analyzing related patents and applications.
  • Legal Considerations: Presumption of validity, ODP, and PTA are critical legal aspects to consider when managing patents.
  • Litigation Trends: Changes in patent laws and the rise of NPEs have significantly impacted patent litigation.
  • Best Practices: Conduct thorough searches and regularly review and update patents to maintain their validity and relevance.

FAQs

Q: What is the significance of independent claims in a patent?

A: Independent claims define the broadest aspects of the invention and stand alone, while dependent claims build upon these independent claims.

Q: How can one identify related patents and applications?

A: Tools like the Global Dossier and the Common Citation Document (CCD) can help identify related patents and applications filed at participating IP Offices.

Q: What is Obviousness-Type Double Patenting (ODP)?

A: ODP is a legal doctrine that can invalidate patent claims if they are deemed to be obvious variations of earlier patents.

Q: Why is Patent Term Adjustment (PTA) important?

A: PTA can extend the life of a patent due to delays in the prosecution process, but it must be carefully managed to avoid legal issues.

Q: What are some key factors contributing to the increase in patent litigation?

A: Changes in patent laws, such as the America Invents Act (AIA), and the rise of non-practicing entities (NPEs) are significant factors contributing to the increase in patent litigation.

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation, GAO-13-465.
  2. United States Court of Appeals for the Federal Circuit: In re Cellect, LLC, 22-1293.
  3. USPTO: Patent Claims Research Dataset.
  4. USPTO: Search for patents.
  5. U.S. Code: 35 USC 282: Presumption of validity; defenses.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,943,166

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,943,166

PCT Information
PCT FiledApril 26, 2000PCT Application Number:PCT/US00/11129
PCT Publication Date:November 09, 2000PCT Publication Number: WO00/66099

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.